Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             161 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial Richmond, P.C.
2012
30 Supplement 6 p. 6163-6174
12 p.
artikel
2 Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: A population-based survey Arrossi, Silvina
2012
30 Supplement 6 p. 2467-2474
8 p.
artikel
3 Acceptance of a post-partum influenza vaccination (cocooning) strategy for neonates in Greece Maltezou, Helena C.
2012
30 Supplement 6 p. 5871-5874
4 p.
artikel
4 A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination Sabarth, Nicolas
2012
30 Supplement 6 p. 5533-5540
8 p.
artikel
5 A collaborative approach to investigating the risk of thrombocytopenic purpura after measles–mumps–rubella vaccination in England and Denmark Andrews, Nick
2012
30 Supplement 6 p. 3042-3046
5 p.
artikel
6 Active surveillance for influenza vaccine adverse events: The integrated vaccine surveillance system Newes-Adeyi, Gabriella
2012
30 Supplement 6 p. 1050-1055
6 p.
artikel
7 A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children Anh, Dang Duc
2012
30 Supplement 6 p. A114-A121
nvt p.
artikel
8 Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses Honda-Okubo, Yoshikazu
2012
30 Supplement 6 p. 5373-5381
9 p.
artikel
9 Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak Abedi, Glen R.
2012
30 Supplement 6 p. 7052-7058
7 p.
artikel
10 A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children Aquino, Amalia Guadalupe Becerra
2012
30 Supplement 6 p. 6492-6500
9 p.
artikel
11 A genome-wide association study of host genetic determinants of the antibody response to Anthrax Vaccine Adsorbed Pajewski, Nicholas M.
2012
30 Supplement 6 p. 4778-4784
7 p.
artikel
12 Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions Nakayama, Tetsuo
2012
30 Supplement 6 p. 3885-3890
6 p.
artikel
13 Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine Breiman, Robert F.
2012
30 Supplement 6 p. A24-A29
nvt p.
artikel
14 Annual influenza vaccination affects the development of heterosubtypic immunity Bodewes, Rogier
2012
30 Supplement 6 p. 7407-7410
4 p.
artikel
15 A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory Loew-Baselli, Alexandra
2012
30 Supplement 6 p. 5956-5966
11 p.
artikel
16 An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP–IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children Klein, Nicola P.
2012
30 Supplement 6 p. 668-674
7 p.
artikel
17 An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women Jacobsen, Steven J.
2012
30 Supplement 6 p. 4585-4587
3 p.
artikel
18 An update after 16 years of hepatitis B vaccination in South Africa Burnett, Rosemary J.
2012
30 Supplement 6 p. C45-C51
nvt p.
artikel
19 A phase III, randomized controlled study to assess the safety and immunogenicity of a semi-synthetic diphtheria, tetanus and whole-cell pertussis vaccine in Indian infants Sharma, Hitt
2012
30 Supplement 6 p. 6157-6162
6 p.
artikel
20 A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil Weckx, Lily Yin
2012
30 Supplement 6 p. 7566-7572
7 p.
artikel
21 A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age Baxter, Roger
2012
30 Supplement 6 p. 2989-2998
10 p.
artikel
22 A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic Reynales, Humberto
2012
30 Supplement 6 p. 6436-6443
8 p.
artikel
23 A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity Hoft, Daniel F.
2012
30 Supplement 6 p. 2098-2108
11 p.
artikel
24 A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines Schiller, John T.
2012
30 Supplement 6 p. F123-F138
nvt p.
artikel
25 Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process Sharma, Hitt J.
2012
30 Supplement 6 p. 510-516
7 p.
artikel
26 Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs Sanford, Brenton J.
2012
30 Supplement 6 p. 6249-6255
7 p.
artikel
27 Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects Fukase, Hiroyuki
2012
30 Supplement 6 p. 5030-5037
8 p.
artikel
28 Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1) Nayak, Baibaswata
2012
30 Supplement 6 p. 2220-2227
8 p.
artikel
29 Barriers to and facilitators of child influenza vaccine – Perspectives from parents, teens, marketing and healthcare professionals Bhat-Schelbert, Kavitha
2012
30 Supplement 6 p. 2448-2452
5 p.
artikel
30 Broad HIV-1 neutralizing antibody response induced by heterologous gp140/gp145 DNA prime-vaccinia boost immunization Liu, Lianxing
2012
30 Supplement 6 p. 4135-4143
9 p.
artikel
31 Calcineurin B subunit triggers innate immunity and acts as a novel Engerix-B® HBV vaccine adjuvant Hu, Minling
2012
30 Supplement 6 p. 4719-4727
9 p.
artikel
32 Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming van der Velden, Maikel V.W.
2012
30 Supplement 6 p. 6127-6135
9 p.
artikel
33 Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco) Elmdaghri, Naima
2012
30 Supplement 6 p. G46-G50
nvt p.
artikel
34 Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study Opel, Douglas J.
2012
30 Supplement 6 p. 1269-1275
7 p.
artikel
35 Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination Menon, Vinay J.
2012
30 Supplement 6 p. 3136-3144
9 p.
artikel
36 Co-administration of attenuated Mycoplasma hyopneumoniae 168 strain with bacterial DNA enhances the local and systemic immune response after intranasal vaccination in pigs Li, Yunfeng
2012
30 Supplement 6 p. 2153-2158
6 p.
artikel
37 Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats Pravetoni, M.
2012
30 Supplement 6 p. 4617-4624
8 p.
artikel
38 Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study Chatterjee, Archana
2012
30 Supplement 6 p. 3360-3368
9 p.
artikel
39 Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age Halperin, Scott A.
2012
30 Supplement 6 p. 2556-2563
8 p.
artikel
40 Construction of chimeric bovine viral diarrhea viruses containing glycoprotein Erns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV Luo, Yugang
2012
30 Supplement 6 p. 3843-3848
6 p.
artikel
41 Corynebacterium pyruviciproducens promotes the production of ovalbumin specific antibody via stimulating dendritic cell differentiation and up-regulating Th2 biased immune response Qingzhen, Han
2012
30 Supplement 6 p. 1115-1123
9 p.
artikel
42 Design and initiation of a study to assess the direct and indirect effects of influenza vaccine given to children in rural India Sullender, Wayne
2012
30 Supplement 6 p. 5235-5239
5 p.
artikel
43 Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response Taylor, David N.
2012
30 Supplement 6 p. 5761-5769
9 p.
artikel
44 Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine Bodemer, Nicolai
2012
30 Supplement 6 p. 3747-3756
10 p.
artikel
45 Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues Montiel, Nestor
2012
30 Supplement 6 p. 1690-1701
12 p.
artikel
46 Editorial Board 2012
30 Supplement 6 p. CO2-
1 p.
artikel
47 Editorial Board 2012
30 Supplement 6 p. CO2-
1 p.
artikel
48 Editorial Board 2012
30 Supplement 6 p. CO2-
1 p.
artikel
49 Editorial Board/Aims and Scope 2012
30 Supplement 6 p. CO2-
1 p.
artikel
50 Editorial Board/Aims and Scope 2012
30 Supplement 6 p. CO2-
1 p.
artikel
51 Editorial Board/Aims and Scope 2012
30 Supplement 6 p. CO2-
1 p.
artikel
52 Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience Djingarey, Mamoudou H.
2012
30 Supplement 6 p. B40-B45
nvt p.
artikel
53 Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza Örtqvist, Åke
2012
30 Supplement 6 p. 5699-5702
4 p.
artikel
54 Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: A cluster randomized trial in Karachi, Pakistan Khan, M. Imran
2012
30 Supplement 6 p. 5389-5395
7 p.
artikel
55 Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users Tran, Thanh Q.
2012
30 Supplement 6 p. 342-349
8 p.
artikel
56 Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs Linhares, Daniel C.L.
2012
30 Supplement 6 p. 407-413
7 p.
artikel
57 Effect of needle length for response to hepatitis B vaccine in macrosomic neonates: A prospective randomized study Ozdemir, Ramazan
2012
30 Supplement 6 p. 3155-3158
4 p.
artikel
58 Effect of the vaccination scheme on PregSure®BVD induced alloreactivity and the incidence of Bovine Neonatal Pancytopenia Kasonta, Rahel
2012
30 Supplement 6 p. 6649-6655
7 p.
artikel
59 Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial Le Corre, Nicole
2012
30 Supplement 6 p. 7522-7528
7 p.
artikel
60 Effects of immunization with natural and recombinant lysine decarboxylase on canine gingivitis development Peters, Jennifer L.
2012
30 Supplement 6 p. 6706-6712
7 p.
artikel
61 Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial Madhi, S.A.
2012
30 Supplement 6 p. A44-A51
nvt p.
artikel
62 Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.) Abd Alla, Mohamed D.
2012
30 Supplement 6 p. 3068-3075
8 p.
artikel
63 Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions Seo, Hwi Won
2012
30 Supplement 6 p. 6671-6677
7 p.
artikel
64 Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial Cunliffe, Nigel A.
2012
30 Supplement 6 p. A36-A43
nvt p.
artikel
65 Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya Feikin, Daniel R.
2012
30 Supplement 6 p. A52-A60
nvt p.
artikel
66 Efficacy of the oral pentavalent rotavirus vaccine in Mali Sow, Samba O.
2012
30 Supplement 6 p. A71-A78
nvt p.
artikel
67 Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: A 6-month prospective study Drolet, Mélanie
2012
30 Supplement 6 p. 2047-2050
4 p.
artikel
68 Enhancing immune responses to inactivated porcine parvovirus oil emulsion vaccine by co-inoculating porcine transfer factor in mice Wang, Rui-ning
2012
30 Supplement 6 p. 5246-5252
7 p.
artikel
69 Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon Hanna-Wakim, Rima
2012
30 Supplement 6 p. G11-G17
nvt p.
artikel
70 Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac Caron, François
2012
30 Supplement 6 p. 5059-5062
4 p.
artikel
71 Factors associated with HPV vaccine uptake in teenage girls: A systematic review Kessels, Sharon J.M.
2012
30 Supplement 6 p. 3546-3556
11 p.
artikel
72 Feasibility of a randomized controlled trial to evaluate Text Reminders for Immunization Compliance in Kids (TRICKs) Ahlers-Schmidt, Carolyn R.
2012
30 Supplement 6 p. 5305-5309
5 p.
artikel
73 Febrile seizures after 2010–2011 influenza vaccine in young children, United States: A vaccine safety signal from the vaccine adverse event reporting system Leroy, Z.
2012
30 Supplement 6 p. 2020-2023
4 p.
artikel
74 Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: Potential benefits of rotavirus vaccine Groome, Michelle J.
2012
30 Supplement 6 p. A173-A178
nvt p.
artikel
75 Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak Williams, Roxanne E.
2012
30 Supplement 6 p. 3147-3150
4 p.
artikel
76 HIV vaccine candidates generate in vitro T cell response to putative epitopes in Chinese-origin rhesus macaques Liao, Qi
2012
30 Supplement 6 p. 1601-1608
8 p.
artikel
77 Homeschooling parents’ practices and beliefs about childhood immunizations Thorpe, Elizabeth L.
2012
30 Supplement 6 p. 1149-1153
5 p.
artikel
78 How influenza vaccination policy may affect vaccine logistics Assi, Tina-Marie
2012
30 Supplement 6 p. 4517-4523
7 p.
artikel
79 Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis Gillison, Maura L.
2012
30 Supplement 6 p. F34-F54
nvt p.
artikel
80 Human papillomavirus, lichen sclerosus and penile cancer: A study in Belgium D’Hauwers, K.W.M.
2012
30 Supplement 6 p. 6573-6577
5 p.
artikel
81 Humoral and cellular immune response generated by different vaccine programs before and after Salmonella Enteritidis challenge in chickens Penha Filho, Rafael Antonio Casarin
2012
30 Supplement 6 p. 7637-7643
7 p.
artikel
82 Immunization coverage and timeliness of vaccination in Italian children with chronic diseases Pandolfi, E.
2012
30 Supplement 6 p. 5172-5178
7 p.
artikel
83 Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan Huang, Li-Min
2012
30 Supplement 6 p. 2054-2059
6 p.
artikel
84 Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults Hakim, Hana
2012
30 Supplement 6 p. 879-885
7 p.
artikel
85 Immunogenicity and safety of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, compared with Hiberix™ in Korean infants and children: A randomized trial Kim, Kyung-Hyo
2012
30 Supplement 6 p. 1886-1894
9 p.
artikel
86 Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru Lanata, Claudio F.
2012
30 Supplement 6 p. 5935-5941
7 p.
artikel
87 Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam Shin, Sunheang
2012
30 Supplement 6 p. A106-A113
nvt p.
artikel
88 Immunogenicity of the pentavalent rotavirus vaccine in African infants Armah, George E.
2012
30 Supplement 6 p. A86-A93
nvt p.
artikel
89 Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge Cox, Josephine H.
2012
30 Supplement 6 p. 1830-1840
11 p.
artikel
90 Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects Vardas, Eftyhia
2012
30 Supplement 6 p. 4046-4054
9 p.
artikel
91 Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo Daenthanasanmak, Anusara
2012
30 Supplement 6 p. 5118-5131
14 p.
artikel
92 Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children Zhang, Zhi-Lun
2012
30 Supplement 6 p. 4028-4033
6 p.
artikel
93 International collaborative proficiency study of Human Papillomavirus type 16 serology Eklund, Carina
2012
30 Supplement 6 p. 294-299
6 p.
artikel
94 Introducing human papillomavirus vaccines into the health system in South Africa Botha, Matthys H.
2012
30 Supplement 6 p. C28-C34
nvt p.
artikel
95 Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa Schoub, Barry D.
2012
30 Supplement 6 p. C35-C37
nvt p.
artikel
96 In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system Childs, Tawanna S.
2012
30 Supplement 6 p. 5942-5948
7 p.
artikel
97 Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination Li, Xi
2012
30 Supplement 6 p. 4581-4584
4 p.
artikel
98 Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs Berk, Erik
2012
30 Supplement 6 p. 6216-6224
9 p.
artikel
99 Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice Miyata, Takeshi
2012
30 Supplement 6 p. 948-958
11 p.
artikel
100 Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh Zaman, K.
2012
30 Supplement 6 p. A94-A100
nvt p.
artikel
101 Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine Desai, Kamal
2012
30 Supplement 6 p. 2510-2515
6 p.
artikel
102 Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice Nanjundappa, Roopa Hebbandi
2012
30 Supplement 6 p. 3519-3525
7 p.
artikel
103 Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity Sáez, Darwin
2012
30 Supplement 6 p. 1283-1290
8 p.
artikel
104 Parental and societal values for the risks and benefits of childhood combination vaccines Gidengil, Courtney
2012
30 Supplement 6 p. 3445-3452
8 p.
artikel
105 Pediatric influenza immunization in an integrated safety net health care system O’Connor, Mary E.
2012
30 Supplement 6 p. 2951-2955
5 p.
artikel
106 Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance Nilsson, Lennart
2012
30 Supplement 6 p. 3239-3247
9 p.
artikel
107 Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age Dayan, Gustavo H.
2012
30 Supplement 6 p. 6656-6664
9 p.
artikel
108 Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide Zollinger, Wendell D.
2012
30 Supplement 6 p. 712-721
10 p.
artikel
109 Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection Parlane, Natalie A.
2012
30 Supplement 6 p. 580-588
9 p.
artikel
110 Polymorphisms in key innate immune genes and their effects on measles vaccine responses and vaccine failure in children from Mozambique Clifford, Holly D.
2012
30 Supplement 6 p. 6180-6185
6 p.
artikel
111 Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia Benavides, Juan Alberto
2012
30 Supplement 6 p. 5886-5892
7 p.
artikel
112 Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil Andrade, Ana Lucia
2012
30 Supplement 6 p. 1901-1909
9 p.
artikel
113 Potential impact of accelerating the primary dose of rotavirus vaccine in infants Halvorson, Elizabeth E.
2012
30 Supplement 6 p. 2738-2741
4 p.
artikel
114 Potential impact of parental Tdap immunization on infant pertussis hospitalizations Peters, Timothy R.
2012
30 Supplement 6 p. 5527-5532
6 p.
artikel
115 Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine Ehrlich, Hartmut J.
2012
30 Supplement 6 p. 4543-4551
9 p.
artikel
116 Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines Monsonego, Joseph
2012
30 Supplement 6 p. 5215-5221
7 p.
artikel
117 Prevention and synergistic control of Ph+ ALL by a DNA vaccine and 6-mercaptopurine Köchling, Joachim
2012
30 Supplement 6 p. 5949-5955
7 p.
artikel
118 Progressive changes in pneumococcal carriage in children attending daycare in Portugal after 6 years of gradual conjugate vaccine introduction show falls in most residual vaccine serotypes but no net replacement or trends in diversity Rodrigues, Fernanda
2012
30 Supplement 6 p. 3951-3956
6 p.
artikel
119 Protective immunity against tick infestation in cattle vaccinated with recombinant trypsin inhibitor of Rhipicephalus microplus Andreotti, Renato
2012
30 Supplement 6 p. 6678-6685
8 p.
artikel
120 Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant Gordon, David L.
2012
30 Supplement 6 p. 5407-5416
10 p.
artikel
121 Randomized trial of HPV4 vaccine assessing the response to HPV4 vaccine in two schedules among Peruvian female sex workers Brown, Brandon
2012
30 Supplement 6 p. 2309-2314
6 p.
artikel
122 Reduction of HPV infections through vaccination among at-risk urban adolescents Cummings, Teresa
2012
30 Supplement 6 p. 5496-5499
4 p.
artikel
123 Repeated dose intramuscular injection of the CIMAvax-EGF vaccine in Sprague Dawley rats induces local and systemic toxicity Mancebo, A.
2012
30 Supplement 6 p. 3329-3338
10 p.
artikel
124 Research priorities for global measles and rubella control and eradication Goodson, James L.
2012
30 Supplement 6 p. 4709-4716
8 p.
artikel
125 Risk factors for low vaccination coverage among Roma children in disadvantaged settlements in Belgrade, Serbia Stojanovski, Kristefer
2012
30 Supplement 6 p. 5459-5463
5 p.
artikel
126 Rotavirus vaccination effectiveness: A case–case study in the EDICS project, Castellón (Spain) Bellido-Blasco, Juan B.
2012
30 Supplement 6 p. 7536-7540
5 p.
artikel
127 Rotavirus vaccination within the South African Expanded Programme on Immunisation Seheri, L. Mapaseka
2012
30 Supplement 6 p. C14-C20
nvt p.
artikel
128 Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: A randomized clinical trial in an Asian population Phua, Kong Boo
2012
30 Supplement 6 p. 4552-4557
6 p.
artikel
129 Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States Krishnarajah, Girishanthy
2012
30 Supplement 6 p. 3717-3722
6 p.
artikel
130 Rubella control in Papua New Guinea: Age-specific immunity informs strategies for introduction of rubella vaccine Riddell, Michaela
2012
30 Supplement 6 p. 7506-7512
7 p.
artikel
131 Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children Okada, Kenji
2012
30 Supplement 6 p. 5967-5972
6 p.
artikel
132 Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates Minervini, Gianmaria
2012
30 Supplement 6 p. 1476-1480
5 p.
artikel
133 Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: Data from two multicentre randomised trials Peeters, Mathieu
2012
30 Supplement 6 p. 6483-6491
9 p.
artikel
134 Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults Seiberling, Michael
2012
30 Supplement 6 p. 7455-7460
6 p.
artikel
135 Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, double-blind, placebo-controlled trial in Chinese males and females Li, Rongcheng
2012
30 Supplement 6 p. 4284-4291
8 p.
artikel
136 Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine Tambyah, Paul A.
2012
30 Supplement 6 p. 329-335
7 p.
artikel
137 Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq®, in Kenya, including among HIV-infected and HIV-exposed infants Laserson, Kayla F.
2012
30 Supplement 6 p. A61-A70
nvt p.
artikel
138 Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age Vermeulen, Joost N.
2012
30 Supplement 6 p. 904-910
7 p.
artikel
139 School-located influenza immunization programs: Factors important to parents and students Middleman, Amy B.
2012
30 Supplement 6 p. 4993-4999
7 p.
artikel
140 Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa Tapia, Milagritos D.
2012
30 Supplement 6 p. A79-A85
nvt p.
artikel
141 Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004–2009. Is rubella susceptibility increasing? Byrne, Lisa
2012
30 Supplement 6 p. 161-167
7 p.
artikel
142 Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010–2011 Tse, Alison
2012
30 Supplement 6 p. 2024-2031
8 p.
artikel
143 Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan Su, Fu-Hsiung
2012
30 Supplement 6 p. 4034-4039
6 p.
artikel
144 SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses Lai, Lilin
2012
30 Supplement 6 p. 1737-1745
9 p.
artikel
145 Stability of a formalin-inactivated Rift Valley fever vaccine: Evaluation of a vaccination campaign for cattle in Mozambique Lagerqvist, N.
2012
30 Supplement 6 p. 6534-6540
7 p.
artikel
146 The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: A randomized controlled trial Dagan, Ron
2012
30 Supplement 6 p. 5132-5140
9 p.
artikel
147 The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies Ambrose, Christopher S.
2012
30 Supplement 6 p. 886-892
7 p.
artikel
148 The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks Qian, Cheng
2012
30 Supplement 6 p. 6279-6286
8 p.
artikel
149 The immunogenicity and safety of a single 0.5mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: Data from a randomized, Phase III study Esposito, Susanna
2012
30 Supplement 6 p. 7005-7012
8 p.
artikel
150 The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong Chiu, Susan S.
2012
30 Supplement 6 p. 1895-1900
6 p.
artikel
151 The role of nasal IgA in children vaccinated with live attenuated influenza vaccine Ambrose, Christopher S.
2012
30 Supplement 6 p. 6794-6801
8 p.
artikel
152 The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines McElhaney, Janet E.
2012
30 Supplement 6 p. 2060-2067
8 p.
artikel
153 Transmission of a live Eimeria acervulina vaccine strain and response to infection in vaccinated and contact-vaccinated broilers Velkers, Francisca C.
2012
30 Supplement 6 p. 322-328
7 p.
artikel
154 UK parents’ decision-making about measles–mumps–rubella (MMR) vaccine 10 years after the MMR-autism controversy: A qualitative analysis Brown, Katrina F.
2012
30 Supplement 6 p. 1855-1864
10 p.
artikel
155 Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo Zaitseva, Marina
2012
30 Supplement 6 p. 4859-4865
7 p.
artikel
156 Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults Potsch, D.V.
2012
30 Supplement 6 p. 5973-5977
5 p.
artikel
157 Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): Impact on the timeliness of uptake of the primary course of DTPa vaccine Wendy, Bissinger
2012
30 Supplement 6 p. 5293-5297
5 p.
artikel
158 Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco Braikat, Mohamed
2012
30 Supplement 6 p. 2594-2599
6 p.
artikel
159 7-Valent pneumococcal conjugate vaccine and otitis media: Effectiveness of a 2-dose versus 3-dose primary series Stoecker, Charles
2012
30 Supplement 6 p. 6256-6262
7 p.
artikel
160 Why did patients with cardiovascular disease in the Netherlands accept Q fever vaccination? Bults, Marloes
2012
30 Supplement 6 p. 3369-3375
7 p.
artikel
161 Workshop on intussusception in African countries – Meeting report Steele, A. Duncan
2012
30 Supplement 6 p. A185-A189
nvt p.
artikel
                             161 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland